The InFLAMES (Innovation Ecosystem Based on the Immune System) Flagship is one of the ten extensive research projects funded by the Academy of Finland. The goals of the InFLAMES Flagship are to identify new targets for drug development and to engage in drug development together with biotechnology and pharmaceutical companies. The Flagship also seeks breakthroughs in diagnostics and personalised medicine. | Professor Sarah Coupland Specialises in Eye Cancers, and in molecular- and digital pathology |
The expertise in the Flagship will be strengthened by Professor Petter Brodin, Professor Sarah Coupland, Dr Simon Goodman, and Professor Reijo Salonen. Their terms will last until the end of 2024. See full article